Ablative Solutions Inc. of Kalamazoo has been recognized as one of two innovators of the year awarded by Medical Main Street's first medical device conference, called Inno-vention 2012, reports Crain's Detroit Business. Ablative Solutions' CEO is Tim Fischell, M.D., a professor of medicine at Michigan State University and the medical director of the Borgess Heart Institute's department of cardiovascular research in Kalamazoo.
Excerpt: Ablative Solutions uses catheters to damage nerve fibers that pass from the brain to the kidney. The damaged nerves send fewer signals in sick patients, which lowers blood pressure and can treat hypertension and congestive heart failure. A prototype device has proved proof of principle, and human trials are expected to begin in the second quarter next year.
For more, please read the
rest of the story.
Source: Crain's Detroit
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.